Hansoh Pharmaceutical Group Company Limited (3692.HK)
HKD 18.5
(0.11%)
HKD 18.5
(0.11%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 575.78 Million CNY | 28.55% |
| 2022 | 447.89 Million CNY | 9.21% |
| 2021 | 410.12 Million CNY | 37.29% |
| 2020 | 298.72 Million CNY | -27.9% |
| 2019 | 414.34 Million CNY | -24.12% |
| 2018 | 546.05 Million CNY | 3.51% |
| 2017 | 527.55 Million CNY | 33.8% |
| 2016 | 394.28 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 599.5 Million CNY | 0.0% |
| 2023 Q2 | 600.38 Million CNY | 0.0% |
| 2023 Q4 | 575.78 Million CNY | 0.0% |
| 2023 FY | 575.78 Million CNY | 28.55% |
| 2022 Q4 | 447.89 Million CNY | 0.0% |
| 2022 FY | 447.89 Million CNY | 9.21% |
| 2022 Q2 | 497.12 Million CNY | 0.0% |
| 2021 Q4 | 410.12 Million CNY | 0.0% |
| 2021 FY | 410.12 Million CNY | 37.29% |
| 2021 Q2 | 328.96 Million CNY | 0.0% |
| 2020 FY | 298.72 Million CNY | -27.9% |
| 2020 Q4 | 298.72 Million CNY | 0.0% |
| 2020 Q2 | 385.42 Million CNY | 0.0% |
| 2019 FY | 414.34 Million CNY | -24.12% |
| 2019 Q4 | 414.34 Million CNY | 0.0% |
| 2019 Q2 | 422.18 Million CNY | 0.0% |
| 2018 FY | 546.05 Million CNY | 3.51% |
| 2018 Q3 | 546.68 Million CNY | 0.0% |
| 2018 Q4 | 546.05 Million CNY | -0.12% |
| 2017 FY | 527.55 Million CNY | 33.8% |
| 2016 FY | 394.28 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 12.19 Million HKD | -4620.686% |
| Grand Pharmaceutical Group Limited | 1.38 Billion HKD | 58.537% |
| Extrawell Pharmaceutical Holdings Limited | 7.26 Million HKD | -7825.423% |
| Wai Yuen Tong Medicine Holdings Limited | 308.09 Million HKD | -86.883% |
| Qianhai Health Holdings Limited | 431.78 Million HKD | -33.349% |
| Lee's Pharmaceutical Holdings Limited | 298.1 Million HKD | -93.147% |
| Essex Bio-Technology Limited | 62.82 Million HKD | -816.53% |
| Tongfang Kontafarma Holdings Limited | 98.26 Million HKD | -485.942% |
| PuraPharm Corporation Limited | 175.59 Million HKD | -227.9% |
| SSY Group Limited | 1.08 Billion HKD | 46.995% |
| JBM (Healthcare) Limited | 91.58 Million HKD | -528.686% |
| Jacobson Pharma Corporation Limited | 317.85 Million HKD | -81.145% |
| China Resources Pharmaceutical Group Limited | 35.09 Billion HKD | 98.359% |